Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cerebral venous thrombosis].

Aude Triquenot-Bagan1

  • 1Département de neurologie, CHU de Rouen. Aude.triquenot-Bagan@chu-rouen.fr

Presse Medicale (Paris, France : 1983)
|February 14, 2007
PubMed
Summary
This summary is machine-generated.

Cerebral venous thrombosis (CVT) is a rare condition often difficult to diagnose due to varied symptoms. Prompt antithrombotic treatment is crucial, even with bleeding risks, to mitigate permanent neurological damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcome following best medical management in acute stroke with a proximal isolated occlusion of the anterior cerebral artery: an international multicentre study.

European stroke journal·2026
Same author

Predictors of poor outcome in acute stroke patients with posterior cerebral artery occlusion and medical management.

International journal of stroke : official journal of the International Stroke Society·2024
Same author

Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative Study.

Neurology·2024
Same author

Yoga in the Rehabilitation of Post-Stroke Sequelae: A Non-Inferiority Randomized Controlled Trial.

Journal of integrative and complementary medicine·2023
Same author

Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study.

Stroke·2023
Same author

Recanalization Treatments for Pediatric Acute Ischemic Stroke in France.

JAMA network open·2022
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Neurology
  • Vascular Medicine
  • Hematology

Context:

  • Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular event.
  • Diagnosis is challenging due to polymorphic clinical presentations and onset.
  • Magnetic Resonance Imaging (MRI) with angiographic sequences aids in diagnosis.

Purpose:

  • To summarize the key aspects of cerebral venous thrombosis.
  • To highlight diagnostic challenges and imaging modalities.
  • To discuss causes, risk factors, and treatment implications.

Summary:

  • CVT is rare, with hemostatic disorders like thrombophilia, often combined with factors like oral contraception, being primary causes, particularly in young women.
  • Idiopathic CVT accounts for about 20% of cases.

Related Experiment Videos

  • Antithrombotic therapy is essential immediately upon diagnosis, irrespective of concurrent hemorrhagic lesions.
  • Impact:

    • Early diagnosis and treatment of CVT can reduce the risk of permanent neurological deficits.
    • Understanding risk factors, such as thrombophilia and oral contraceptive use, is vital for prevention and management.
    • The condition carries a significant risk of permanent neurologic damage, estimated at 13%.